ACR/ARHP Poster Session C Direskeneli 11 , Sibel Z. Aydin 11 , Colin Pease 20 , Khalid Ahmed 13 , Mehrdad Mazlumzadeh 7 , Andy Abril 5 , Neil Gonter 21 , Hilal Maradit-Kremers 3 , Cynthia S. Crowson 3 , Bhaskar Dasgupta 14 and Eric L. Matteson 6 , 13 rd <strong>Rheumatology</strong> Department, National Institute <strong>of</strong> <strong>Rheumatology</strong> and Physiotherapy, Budapest, 2 Center for Diagnosis Imaging, Hospital Clínic, Montserrat del Amo, Barcelona, Spain, 3 Department <strong>of</strong> Health Sciences Research, Mayo Clinic, Rochester, MN, 4 Department <strong>of</strong> Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria, 5 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Jacksonville, FL, 6 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Rochester, MN, 7 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Scottsdale, AZ, 8 Department <strong>of</strong> Internal Medicine, General Hospital <strong>of</strong> the Elisabethinen, Klagenfurt, Austria, 9 Department <strong>of</strong> Internal Medicine, University <strong>of</strong> Genova, Genova, Italy, 10 Department <strong>of</strong> <strong>Rheumatology</strong>, Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 11 Department <strong>of</strong> <strong>Rheumatology</strong>, Marmara University Medical School, Istanbul, Turkey, 12 Department <strong>of</strong> <strong>Rheumatology</strong>, Medical University, Graz, Graz, Austria, 13 Department <strong>of</strong> <strong>Rheumatology</strong>, Princess Alexandra Hospital, Harlow, United Kingdom, 14 Department <strong>of</strong> <strong>Rheumatology</strong>, Southend University Hospital, Essex, United Kingdom, 15 Department <strong>of</strong> Systemic Autoimmune Hospital Clinic Provincial, Barcelona, Spain, 16 Deptartment <strong>of</strong> Internal Medicine and <strong>Rheumatology</strong>, WIM CSK MON, Warszawa, Poland, 17 Immanuel Krankenhaus Berlin: Medical Center for <strong>Rheumatology</strong> Berlin-Buch Berlin, Berlin, Germany, 18 National Institute <strong>of</strong> <strong>Rheumatology</strong> and Physiotherapy, Budapest, Hungary, 19 Radiology Department, National Institute <strong>of</strong> <strong>Rheumatology</strong> and Physiotherapy, Budapest, Hungary, 20 <strong>Rheumatology</strong> and Rehabilitation Research Unit, University <strong>of</strong> Leeds, Leeds, UK, 21 <strong>Rheumatology</strong> Associates <strong>of</strong> North Jersey, Teaneck, NJ, 22 <strong>Rheumatology</strong> Unit, Clinica e Terapia Medica Department, Sapienza Università di Roma, Policlinico Umberto I, Rome, Italy, 23 Sahlgren University Hospital, Department <strong>of</strong> <strong>Rheumatology</strong>, Göteborg, Sweden. Infection-Related Rheumatic Disease 1638. A Comparison <strong>of</strong> the Presentation, Synovial Fluid Analysis, and Treatment Course in Children and Adults with Lyme Arthritis. Brian E. Daikh 4 , Fred Emerson 3 , F. Lee Lucas 2 , Robert Smith 1 and Carol McCarthy 1 , 1 Maine Medical Center, 2 Maine Medical Center Research Institute, 3 Maine Medical Partners, 4 <strong>Rheumatology</strong> Associates PC, Portland, ME. 1639. Autoantibodies to a Novel Cytoplasmic Rod/Ring Structure Target CTP/GTP Synthetic Pathway in HCV Infection after Interferon/Ribavirin Therapy. Wendy C. Carcamo 2 , Angela Ceribelli 3 , Jason Y. F Chan 3 , Westley H. Reeves 2 , Giovanni Covini, Carlos A. Von Muhlen 1 , Liu Chen 3 , Minoru Satoh 2 and Edward K. .L Chan 2 , 1 Metanalysis, Porto Alegre, Brazil, 2 University <strong>of</strong> Florida, Gainesville, FL, 3 University <strong>of</strong> Florida. 1640. Chloroquine (CQN) Is Not Superior to Meloxicam (MCAM) in the Treatment <strong>of</strong> Early Persistent ‘Musculoskeletal Pain and Polyarthralgias’ (MSK-P) Following Chikungunya (CHIKV): A Non Commercial Investigator Initiated Community Based Controlled Drug Study. Arvind Chopra 2 , Manjit Saluja 3 and Anuradha Venugopalan 1 , 1 Center for Rheuamatic Diseases, 2 Center for Rheumatic Diseases, Pune, India, 3 Center for Rheumatic Diseases. 1641. Clinical Features <strong>of</strong> Acute Human Parvovirus B19 in Adults: What We Could Learn from It? Hideto Oshikawa 1 , Makiko Yamamoto 2 , Akira Jibatake 2 , Kiyoharu Muranaka 2 , Kazuki Yoshida 2 , Masako Utsunomiya 2 , Tatsuo Kobayashi 2 , Mitsumasa Kishimoto 3 and Kazuo Matsui 2 , 1 Department <strong>of</strong> <strong>Rheumatology</strong>, Kameda Medical Center, Kamogawa City, Chiba, Japan, 2 Department <strong>of</strong> <strong>Rheumatology</strong>, Kameda Medical Center, 3 St Luke’s International Hospital, Japan. 1642. Cytokines in Chikungunya (CHIKV): Storm in a Teacup or Winds before the Storm. Arvind Chopra 2 and Anuradha Venugopalan 1 , 1 Center for Rheumatic Disease, Pune, India, 2 Center for Rheumatic Diseases, Pune, India. 1643. Geographic Distribution <strong>of</strong> Endemic Fungal Infections among Older <strong>American</strong>s. John W. Baddley 3 , Kevin L. Winthrop 1 , Nivedita M. Patkar 3 , Elizabeth Delzell 4 , Fenglong Xie 4 , Lang Chen 4 and Jeffrey R. Curtis 2 , 1 Oregon Health Sciences University, 2 University <strong>of</strong> Alabama - Brimingham, Birmingham, AL, 3 University <strong>of</strong> Alabama at Birmingham, Birmingham, AL, 4 University <strong>of</strong> Alabama at Birmingham, Birmingham, AL. 1644. Identification <strong>of</strong> Borrelia Burgdorferi in Brazil: The Etiologic Agent <strong>of</strong> Brazilian Lyme Disease-Like Syndrome (Baggio- Yoshinari Syndrome). Elenice Mantovani, Roberta G. Marangoni, Giancarla Gauditano, Virgínia L. N. Bonoldi and Natalino H. Yoshinari, <strong>Rheumatology</strong> Division, Faculdade de Medicina da Universidade de São Paulo. 1645. Prevalence, Impact and Risk Factors for Musculoskeletal Pain among HIV Infected Adults: An Epidemiologic Study. Karen Walker-Bone 1 , Edwina Lawson 2 , Duncan Churchill 2 , Yvonne Gilleece 2 , Martin Fisher 2 and Caroline Sabin 3 , 1 Brighton &Sussex Medical School, Brighton, United Kingdom, 2 Brighton &Sussex University Hospitals NHS Trust, 3 University <strong>College</strong>, London. 1646. Surrogate Markers <strong>of</strong> B-Cell Non-Hodgkin Lymphoma in Patients with Hepatitis C Virus-Related Cryoglobulinemia Vasculitis. Guillaume Geri 2 , Benjamin Terrier 2 , Oren Semoun 1 , David Saadoun 2 , Damien Sène 2 , Hélène Merle-Beral 2 , Frédéric Charlotte 2 , Lucile Musset 2 , Mathieu Resche-Rigon 1 and Patrice Cacoub 2 , 1 INSERM URMS 717, Paris 7 , Paris, France, 2 Pitié- Salpetrière Hospital, Paris, France. 1647. The Diagnosis <strong>of</strong> Reactive Arthritis in the Real World and Factors That Might Contribute to Its Under/Misdiagnosis. Jenny Lin 2 , Anjali G. Shetty 2 and John D. Carter 1 , 1 Univ <strong>of</strong> South Florida, Tampa, FL, 2 University <strong>of</strong> South Florida. 1648. The Infectious Risk <strong>of</strong> the Lower Respiratory Tract Is Increased in Patients with Rheumatic Diseases Treated by Biologic DMARDs, in Particular in Case <strong>of</strong> Pre-Existing Colonisation. Guillaume Geri, Sabrina Dadoun, Simon Paternotte, Maxime Dougados and Laure Gossec, Cochin Hospital, Paris, France. 1649. Usefulness <strong>of</strong> Procalcitonin Measurement in Differentiating between Activity <strong>of</strong> Systemic Autoimmune Disease and Bacterial Infection. Olga Sleglova 3 , Helena Dejmkova 4 , Jana Uhrova 2 and Jaromir Belacek 1 , 1 Department <strong>of</strong> Biostatistics, 1 . Medical Faculty, Charles University, Prague, Czech Republic, 2 Institute <strong>of</strong> Clinical Biochemistry, Prague, Czech Republic, Czech Republic, 3 Institute <strong>of</strong> <strong>Rheumatology</strong>, Prague, Czech Republic, 4 Institute <strong>of</strong> <strong>Rheumatology</strong>, Prague, Czech Republic. 246 2010 Program Book
ACR/ARHP Poster Session C Miscellaneous Rheumatic and Inflammatory Diseases II 1650. Adalimumab Therapy in 18 Patients with Severe Hidradenitis Suppurativa. Orlando Pompei Fernández 5 , Ricardo Blanco Alonso 5 , Ignacio Villa 4 , Marcos Gonzalez López 2 , Hector Fernández LLaca 1 , M. Del Carmen González-Vela 3 , Mario Agudo Bilbao 6 , Cristina Martinez Dubois 6 , Victor M. Martinez-Taboada 7 , M. Enriqueta Peiro Callizo 5 , Jose Luis Peña Salgredo 5 , Alfonso Fernando Corrales Martinez 5 and Miguel Angel Gonzalez-Gay Mantecon 5 , 1 Department <strong>of</strong> Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, 2 Department <strong>of</strong> Inmunology, Hospital de Liencres, Santander, Cantabria, 3 Department <strong>of</strong> Pathology, Hospital Universitario Marqués de Valdecilla, 4 Department <strong>of</strong> <strong>Rheumatology</strong>, Hospital Sierrallana, 5 Department <strong>of</strong> <strong>Rheumatology</strong>, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 6 Department <strong>of</strong> <strong>Rheumatology</strong>, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, 7 Department <strong>of</strong> <strong>Rheumatology</strong>, Hospital Universitario Marqués de Valdecilla, Santander, Spain. 1651. Association <strong>of</strong> Langerhans Cell Histiocytosis with Erdheim- Chester Disease: How Close Monocyte/Macrophage and Dendritic Cell Lineages Are? Baptiste Hervier, Frrederic Charlotte, Olivier Hermine, Antoine Neel, Nicole Brousse, Aude Rigolet, Christian De gennes, Eric Hachulla, Xavier Girerd, Antoine Dupuy, Zahir Amoura and Julien Haroche, CHU Pitié Salpetrière, APHP, Paris, France, French Reference Center for Lupus. 1652. Blinded Multi-Rater Evaluation <strong>of</strong> Diagnosis and Candidate Classification Criteria for Polymyalgia Rheumatica (PMR). ACR – EULAR Study Group for Development <strong>of</strong> Classification Criteria for PMR. Eric L. Matteson 5 , Marco A. Cimmino 7 , Hilal Maradit-Kremers 1 , Carlo Salvarani 8 , Michael Schirmer 3 , Wolfgang A. Schmidt 13 , Maria C. Cid 12 , Christian Dejaco 10 , Pierre Duhaut 20 , Zsuzsa Schmidt 14 , Annamaria Iagnocco 18 , Artur Bachta 2 , Carlotta Nannini 19 , Fabrizio Cantini 19 , Victor Martínez-Taboada 21 , Haner Direskeneli 9 , Sibel Z. Aydin 9 , Raashid Luqmani 15 , Colin Pease 16 , Mehrdad Mazlumzadeh 6 , Kenneth Calamia 4 , Clement J. Michet 5 , Andy Abril 4 , Neil Gonter 17 , Cynthia S. Crowson 1 , Rickey Carter 1 and Bhaskar Dasgupta 11 , 1 Department <strong>of</strong> Health Sciences Research, Mayo Clinic, Rochester, MN, 2 Department <strong>of</strong> Internal Medicine and <strong>Rheumatology</strong>, WIM CSK MON, Warszawa, Poland, 3 Department <strong>of</strong> Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria, 4 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Jacksonville, FL, 5 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Rochester, MN, 6 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Scottsdale, AZ, 7 Department <strong>of</strong> Internal Medicine, University <strong>of</strong> Genova, Genova, Italy, 8 Department <strong>of</strong> <strong>Rheumatology</strong>, Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 9 Department <strong>of</strong> <strong>Rheumatology</strong>, Marmara University Medical School, Istanbul, Turkey, 10 Department <strong>of</strong> <strong>Rheumatology</strong>, Medical University, Graz, Graz, Austria, 11 Department <strong>of</strong> <strong>Rheumatology</strong>, Southend University Hospital, Essex, United Kingdom, 12 Department <strong>of</strong> Systemic Autoimmune Hospital Clinic Provincial, Barcelona, Spain, 13 Immanuel Krankenhaus Berlin: Medical Center for <strong>Rheumatology</strong> Berlin-Buch Berlin, Berlin, Germany, 14 National Institute <strong>of</strong> <strong>Rheumatology</strong> and Physiotherapy, Budapest, Hungary, 15 Nuffield Department <strong>of</strong> Orthopaedics, <strong>Rheumatology</strong> and Musculoskeletal Sciences, Oxford University, Oxford, UK, 16 <strong>Rheumatology</strong> and Rehabilitation Research Unit, University <strong>of</strong> Leeds, Leeds, UK, 17 <strong>Rheumatology</strong> Associates <strong>of</strong> North Jersey, Teaneck, NJ, 18 <strong>Rheumatology</strong> Unit, Clinica e Terapia Medica Department, Sapienza Università di Roma, Policlinico Umberto I, Rome, Italy, 19 <strong>Rheumatology</strong> Unit, Ospedale Misericordia e Dolce, Prato, Italy, 20 Service de Medecine Interne, Amiens, France, 21 Servicio de Reumatología, Hospital Universitario Marques de Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander, Spain. 1653. Bone Events in Type 1 Gaucher Disease before and during Treatment. Jerome Stirnemann 2 , Djazia Heraoui 1 , Corine Vincent 3 , Olivier Fain 2 , Bruno Fantin 1 , France Mentre 3 and Nadia Belmatoug 1 , 1 APHP - Referral Center <strong>of</strong> Lysosomal Diseases (RCLD), Clichy, France, 2 APHP - Referral Center <strong>of</strong> Lysosomal Diseases (RCLD), Bondy, France, 3 INSERM, Paris, France. 1654. Development <strong>of</strong> Classification Criteria for Polymyalgia Rheumatica (PMR): Results from an International, Prospective, Multi-Center Longitudinal Study ACR – EULAR Study Group for Development <strong>of</strong> Classification Criteria for PMR. Bhaskar Dasgupta 16 , Marco A. Cimmino 10 , Hilal Maradit-Kremers 3 , Wolfgang A. Schmidt 19 , Michael Schirmer 5 , Carlo Salvarani 5 , Peter Mandl 20 , Artur Bachta 4 , Maria Cid 17 , Haner Direskeneli 13 , Pierluigi Macchioni 11 , Peter V. Balint 1 , Christina Duftner 9 , Christian Dejaco 14 , Hanna Slott Jensen 18 , Zsuza Schmidt 20 , Gyula Poór 20 , Annamaria Iagnocco 24 , Victor Martínez-Taboada 28 , Elizabeth Nordborg 26 , Carlotta Nannini 25 , Pierre Duhaut 27 , Nicolò Pipitone 11 , Georgina Espígol-Frigolé 2 , Sibel Z. Aydin 13 , Khalid Ahmed 15 , Raashid Luqmani 21 , Brian Hazelman 12 , Colin Pease 22 , Richard J. Wakefield 22 , Neil Gonter 23 , Ralph Marcus 23 , Clement J. Michet 7 , Mehrdad Mazlumzadeh 8 , Andy Abril 6 , Cynthia S. Crowson 3 and Eric L. Matteson 7 , 13 rd <strong>Rheumatology</strong> Department, National Institute <strong>of</strong> <strong>Rheumatology</strong> and Physiotherapy, Budapest, 2 Center for Diagnosis Imaging, Hospital Clínic, Montserrat del Amo, Barcelona, Spain, 3 Department <strong>of</strong> Health Sciences Research, Mayo Clinic, Rochester, MN, 4 Department <strong>of</strong> Internal Medicine and <strong>Rheumatology</strong>, WIM CSK MON, Warszawa, Poland, 5 Department <strong>of</strong> Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria, 6 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Jacksonville, FL, 7 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Rochester, MN, 8 Department <strong>of</strong> Internal Medicine, Division <strong>of</strong> <strong>Rheumatology</strong>, Mayo Clinic, Scottsdale, AZ, 9 Department <strong>of</strong> Internal Medicine, General Hospital <strong>of</strong> the Elisabethinen, Klagenfurt, Austria, 10 Department <strong>of</strong> Internal Medicine, University <strong>of</strong> Genova, Genova, Italy, 11 Department <strong>of</strong> <strong>Rheumatology</strong>, Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 12 Department <strong>of</strong> <strong>Rheumatology</strong>, Cambridge University, Cambridge, UK, 13 Department <strong>of</strong> <strong>Rheumatology</strong>, Marmara University Medical School, Istanbul, Turkey, 14 Department <strong>of</strong> <strong>Rheumatology</strong>, Medical University, Graz, Graz, Austria, 15 Department <strong>of</strong> <strong>Rheumatology</strong>, Princess Alexandra Hospital, Harlow, United Kingdom, 16 Department <strong>of</strong> <strong>Rheumatology</strong>, Southend University Hospital, Essex, United Kingdom, 17 Department <strong>of</strong> Systemic Autoimmune Hospital Clinic Provincial, Barcelona, Spain, 18 Gent<strong>of</strong>te Hospital, <strong>Rheumatology</strong> Division, Hellerup, Denmark, 19 Immanuel Krankenhaus Berlin: Medical Center for <strong>Rheumatology</strong> Berlin-Buch Berlin, Berlin, Germany, 20 National Institute <strong>of</strong> <strong>Rheumatology</strong> and Physiotherapy, Budapest, Hungary, 21 Nuffield Department <strong>of</strong> Orthopaedics, <strong>Rheumatology</strong> and Musculoskeletal Sciences, Oxford University, Oxford, UK, 22 <strong>Rheumatology</strong> and Rehabilitation Research Unit, University <strong>of</strong> Leeds, Leeds, UK, 23 <strong>Rheumatology</strong> Associates <strong>of</strong> North Jersey, Teaneck, NJ, 24 <strong>Rheumatology</strong> Unit, Clinica e Terapia Medica Department, Sapienza Università di Roma, Policlinico Umberto I, Rome, Italy, 25 <strong>Rheumatology</strong> Unit, Ospedale Misericordia e Dolce, Prato, Italy, 26 Sahlgren University Hospital, Department <strong>of</strong> <strong>Rheumatology</strong>, Göteborg, Sweden, 27 Service de Medecine Interne, Amiens, France, 28 Servicio de Reumatología, Hospital Universitario Marques de Valdecilla, Facultad de Medicina, Universidad de Cantabria, Santander, Spain. 2010 Program Book 247
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS ACCREDITATION . .
- Page 7 and 8:
TABLE OF CONTENTS ACR/ARHP Poster S
- Page 9 and 10:
TABLE OF CONTENTS Systemic Sclerosi
- Page 11 and 12:
the written consent of the ACR is p
- Page 13 and 14:
Shuttle Bus Service See shuttle sig
- Page 15 and 16:
ACR Resource Center Hours: Sunday,
- Page 17 and 18:
ACR Hotels + Map Complimentary shut
- Page 19 and 20:
to the premier meeting in rheumatol
- Page 21 and 22:
ACR Clinical Research Conference c/
- Page 23 and 24:
4:20 PM Germinal Center Reactions A
- Page 25 and 26:
3:30 PM Live Demonstration: Ultraso
- Page 27 and 28:
Upon completion of this session, pa
- Page 29 and 30:
MONDAY, NOVEMBER 8, 2010 ACR/ARHP R
- Page 31 and 32:
B301 Dermatological Manifestations
- Page 33 and 34:
Session Overview: The innate immune
- Page 35 and 36:
Upon completion of this session, pa
- Page 37 and 38:
B308 Inflammatory Eye Disease P/C M
- Page 39 and 40:
and insufficiency • recall source
- Page 41 and 42:
Session Overview: The advent of bio
- Page 43 and 44:
2:45 pm 641. Major Improvements in
- Page 45 and 46:
5 University of Twente and Medisch
- Page 47 and 48:
ACR/ARHP Combined Abstract Session
- Page 49 and 50:
REF 25th Anniversary Celebration 2:
- Page 51 and 52:
5:45 PM 699. Defining Latent and/or
- Page 53 and 54:
Lilian H. D. van Tuyl 8 , Karin Bri
- Page 55 and 56:
ACR REF Special Sessions 4:30 - 6:0
- Page 57 and 58:
REF 5K Run/Walk 6:00 - 8:00 am See
- Page 59 and 60:
• discuss the principles of early
- Page 61 and 62:
ACR Medical Aspects of Rheumatic Di
- Page 63 and 64:
10:00 am 1349. Work as a Daily Chal
- Page 65 and 66:
ACR Plenary Session II: Discovery 2
- Page 67 and 68:
B210 B301 Pediatrics: Periodic Feve
- Page 69 and 70:
Session Overview: As a clinical edu
- Page 71 and 72:
Thomas J. Murphy Ballroom Giant Cel
- Page 73 and 74:
3:45 PM 1367. Serum Urate Levels in
- Page 75 and 76:
A411 Rheumatoid Arthritis - Human E
- Page 77 and 78:
2:45 PM 1405. Development of a Visi
- Page 79 and 80:
4:30 PM Anti-citrullinated Protein
- Page 81 and 82:
of Experimental Orthopedics, Univer
- Page 83 and 84:
5:30 PM 1438. Mortality/Morbidity i
- Page 85 and 86:
5:30 PM 1456. Belimumab, a BLyS-Spe
- Page 87 and 88:
Develly 5 , Bernardo L. F. Fernande
- Page 89 and 90:
7:30 PM Role of IL-1 in Human Artic
- Page 91 and 92:
• compare the prevalence and epid
- Page 93 and 94:
6:45 PM Macrophage Activation Syndr
- Page 95 and 96:
Upon completion of this session, pa
- Page 97 and 98:
Session Overview: This roundtable d
- Page 99 and 100:
B303 Scleroderma: Systemic Sclerosi
- Page 101 and 102:
9:00 - 10:30 am - Poster Hall Morni
- Page 103 and 104:
• describe the role of IL-1 and I
- Page 105 and 106:
Session Overview: For the clinician
- Page 107 and 108:
• identify the aspects for day-to
- Page 109 and 110:
ACR Study Groups 1:00 - 2:00 PM B30
- Page 111 and 112:
Session Overview: Ultrasound and ma
- Page 113 and 114:
Session Overview: Fifty percent of
- Page 115 and 116:
1:20 PM Academic Rheumatology Seth
- Page 117 and 118:
ACR Concurrent Abstract Sessions 2:
- Page 119 and 120:
3:00 PM 2110. Rheumatologists on th
- Page 121 and 122:
2:45 PM 2133. Reasons for Decline i
- Page 123 and 124:
Session Overview: We are witnessing
- Page 125 and 126:
Session Overview: Systemic sclerosi
- Page 127 and 128:
Oaks, CA, 2 Amgen Inc., San Francis
- Page 129 and 130:
5:00 PM 2176. A Role of Autoimmune
- Page 131 and 132:
4:30 PM 2198. Association between V
- Page 133 and 134:
ARHP Concurrent Sessions 4:30 - 6:0
- Page 135 and 136:
THURSDAY, NOVEMBER 11, 2010 ACR/ARH
- Page 137 and 138:
• apply these basic statistics to
- Page 139 and 140:
9:15 AM The ACR/EULAR Definition of
- Page 141 and 142:
Immunology, Oslo University Hospita
- Page 143 and 144:
9:15 AM 2239. Factors Associated wi
- Page 145 and 146:
Upon completion of this session, pa
- Page 147 and 148:
Mikkel Østergaard 6 , Paul Emery 4
- Page 149 and 150:
Ende 4 , 1 Department of Rheumatolo
- Page 151 and 152:
ACR Poster Session A Cytokines, Med
- Page 153 and 154:
ACR Poster Session A 51. Associatio
- Page 155 and 156:
ACR Poster Session A 83. Respirator
- Page 157 and 158:
ACR Poster Session A 121. Bone Dens
- Page 159 and 160:
ACR Poster Session A 142. The Intra
- Page 161 and 162:
ACR Poster Session A 171. Early Pro
- Page 163 and 164:
ACR Poster Session A Pediatric Rheu
- Page 165 and 166:
ACR Poster Session A 233. Prevalenc
- Page 167 and 168:
ACR Poster Session A 266. Subtype S
- Page 169 and 170:
ACR Poster Session A 297. Body Weig
- Page 171 and 172:
ACR Poster Session A 325. Patient R
- Page 173 and 174:
ACR Poster Session A 356. Influence
- Page 175 and 176:
ACR Poster Session A 383. Efficacy
- Page 177 and 178:
ACR Poster Session A 409. Rituximab
- Page 179 and 180:
ACR Poster Session A 441. Recombina
- Page 181 and 182:
ACR Poster Session A 465. Immunoglo
- Page 183 and 184:
ACR Poster Session A 496. IRF8 Alle
- Page 185 and 186:
ACR Poster Session A 521. DC-STAMP
- Page 187 and 188:
ACR Poster Session A 546. Prevalenc
- Page 189 and 190:
ACR Poster Session A 571. Epidemiol
- Page 191 and 192:
ACR Poster Session A 599. Validatio
- Page 193 and 194:
ACR/ARHP Poster Session B Halls B1
- Page 195 and 196:
ACR Poster Session B 767. Economic
- Page 197 and 198: ACR/ARHP Poster Session B 792. The
- Page 199 and 200: ACR/ARHP Poster Session B Universit
- Page 201 and 202: ACR/ARHP Poster Session B 848. Cell
- Page 203 and 204: ACR/ARHP Poster Session B 886. Scre
- Page 205 and 206: ACR/ARHP Poster Session B 909. Regu
- Page 207 and 208: ACR/ARHP Poster Session B 935. The
- Page 209 and 210: ACR/ARHP Poster Session B 967. Frac
- Page 211 and 212: ACR Poster Session B 993. Early Exp
- Page 213 and 214: ACR/ARHP Poster Session B 1022. Com
- Page 215 and 216: ACR/ARHP Poster Session B 1055. Son
- Page 217 and 218: ACR Poster Session B 1084. Gene Exp
- Page 219 and 220: ACR/ARHP Poster Session B 1111. Inc
- Page 221 and 222: ACR Poster Session B hiroshima Memo
- Page 223 and 224: ACR/ARHP Poster Session B 1166. Pre
- Page 225 and 226: ACR/ARHP Poster Session B 1199. Typ
- Page 227 and 228: ACR/ARHP Poster Session B 1225. Phy
- Page 229 and 230: ACR/ARHP Poster Session B 1262. Lat
- Page 231 and 232: ACR/ARHP Poster Session B 1294. End
- Page 233 and 234: ACR/ARHP Poster Session B 1321. Cha
- Page 235 and 236: ACR/ARHP Poster Session C Halls B1
- Page 237 and 238: ACR/ARHP Poster Session C 1495. S10
- Page 239 and 240: ACR/ARHP Poster Session C 1524. Inc
- Page 241 and 242: ACR/ARHP Poster Session C 1555. Pro
- Page 243 and 244: ACR/ARHP Poster Session C 1583. Ass
- Page 245 and 246: ACR/ARHP Poster Session C 1596. Gen
- Page 247: ACR/ARHP Poster Session C 1622. Flu
- Page 251 and 252: ACR/ARHP Poster Session C L. Woodwa
- Page 253 and 254: ACR/ARHP Poster Session C 1692. Res
- Page 255 and 256: ACR/ARHP Poster Session C 1719. Los
- Page 257 and 258: ACR/ARHP Poster Session C 1749. Con
- Page 259 and 260: ACR/ARHP Poster Session C 1780. Tow
- Page 261 and 262: ACR/ARHP Poster Session C 1804. Eff
- Page 263 and 264: ACR/ARHP Poster Session C Immunolog
- Page 265 and 266: ACR/ARHP Poster Session C 2 Departm
- Page 267 and 268: ACR/ARHP Poster Session C CA, 29 Un
- Page 269 and 270: ACR/ARHP Poster Session C 1900. IL-
- Page 271 and 272: ACR/ARHP Poster Session C 1930. Cor
- Page 273 and 274: ACR/ARHP Poster Session C 1958. The
- Page 275 and 276: ACR/ARHP Poster Session C 1988. Cha
- Page 277 and 278: ACR/ARHP Poster Session C 2015. CpG
- Page 279 and 280: ACR/ARHP Poster Session C 2038. Pri
- Page 281 and 282: ACR/ARHP Poster Session C 2070. Ass
- Page 283 and 284: REF Industry Roundtable-supported S
- Page 285 and 286: REF Industry Roundtable-supported S
- Page 287 and 288: INDUSTRY-SUPPORTED POST-CONFERENCE
- Page 289 and 290: 2010 ACR/ARHP Annual Meeting Leader
- Page 291 and 292: 2010 ACR/ARHP Annual Meeting Leader
- Page 293 and 294: FLOOR PLANS 2010 Program Book 291
- Page 295 and 296: VISIT THE EXHIBIT HALL New and inno
- Page 297 and 298: EXHIBITORS La Lettre Du Rhumatologu
- Page 299 and 300:
ACKNOWLEDGEMENTS The ACR, the ARHP
- Page 301 and 302:
ACR/ARHP/REF STAFF LISTING Administ
- Page 303 and 304:
A Ahmed, Rafi, PhD T cell Memory .
- Page 305 and 306:
Cooper, Max D, MD Introduction . .
- Page 307 and 308:
Gerlag, Danielle Marie, MD, PhD The
- Page 309 and 310:
Physical Examination Skills for Imp
- Page 311 and 312:
Meroni, Pierluigi, MD Autoantibodie
- Page 313 and 314:
Rogers, Joan C, PhD, OTR/ L Underst
- Page 315 and 316:
Terkeltaub, Robert, MD Crystallizin
- Page 317 and 318:
A Aarden, L 1825 Aarrass, S 1519, 1
- Page 319 and 320:
Bakker, AAB 1095 Barendregt, B 753
- Page 321 and 322:
Boutin-Le Thi Huong, D 478 Bout-Tab
- Page 323 and 324:
Chatham, WW 457, 1146, 1454, 1457,
- Page 325 and 326:
Daudon, M 875 Daugas, E 2009 Davatc
- Page 327 and 328:
Ehst, B 758 Eicher, JL 688 Eisen, S
- Page 329 and 330:
Gabay, OH 1484 Gaber, T 630, 1418 G
- Page 331 and 332:
Guan, M 965 Guañabens, N 975 Gudbj
- Page 333 and 334:
Homme, CL 730 Honda, E 434 Hong, JY
- Page 335 and 336:
Kambayashi, T 1354 Kamdar, AA 1160
- Page 337 and 338:
Kuller, LH 71 Kumabe, M 1164 Kumaga
- Page 339 and 340:
Looney, C 941 Looney, MR 609 Looney
- Page 341 and 342:
McCarthy, GM 1109, 1306, 1426 McCau
- Page 343 and 344:
Myouzen, K 1577 Mysiw, WJ 2096 Mysl
- Page 345 and 346:
Pans, M 1834 Parra, ER 605, 887 Ped
- Page 347 and 348:
Radka, S 1174 Radner, H 296, 1745 R
- Page 349 and 350:
Sack, KE 1898 Sacli, SF 1312 Saddic
- Page 351 and 352:
1463, 2071, 2140, 2141 Singh, K 212
- Page 353 and 354:
Takahata, M 1492 Takasaki, Y 1731 T
- Page 355 and 356:
636 van Dongen, CJJ 90 Van Doornum,
- Page 357 and 358:
Witte, T 824, 1578, 1579, 2214 Witt
- Page 359 and 360:
A α-galactosylceramide 505 A2A kno
- Page 361 and 362:
Behcet’s syndrome 1284, 1288, 129
- Page 363 and 364:
cost-utility 759, 1539 couples 1324
- Page 365 and 366:
fibroblast like synoviocyte 27 fibr
- Page 367 and 368:
impact 1063, 1325 inactive disease
- Page 369 and 370:
methylation 826, 1253, 1489 methylt
- Page 371 and 372:
233, 234, 240, 243, 252, 262, 268,
- Page 373 and 374:
1599, 1600, 1603, 1605, 1606, 1609,
- Page 375 and 376:
1226, 1227, 1229, 1230, 1231, 1233,
- Page 377 and 378:
Abelson, Abby Goulder, MD Education
- Page 379 and 380:
Massarotti, Elena M, MD Systemic Lu
- Page 381 and 382:
ACR Annual Meeting fellowS-in-train
- Page 383 and 384:
NOTES 2010 Program Book 381
- Page 385 and 386:
Enbrel ® (etanercept) Brief Summar
- Page 387 and 388:
Prescription Enbrel ® (etanercept)